Translation of pharmacogenetics into clinically relevant testing modalities

L. M. Baudhuin, L. J. Langman, D. J. O'Kane

Research output: Contribution to journalShort surveypeer-review

14 Scopus citations


Pharmacogenetics (PGx) relies on the genetic makeup of an individual to predict drug response and efficacy, as well as potential adverse drug events. Significant advances in PGx research have been made since inherited differences in response to such drugs as isoniazid and succinylcholine were explored in the 1950s,1,2 and the clinical utility and application of PGx are especially apparent in some subspecialty areas of chemotherapeutic, psychotropic drug, and anticoagulant therapies.

Original languageEnglish (US)
Pages (from-to)373-376
Number of pages4
JournalClinical pharmacology and therapeutics
Issue number4
StatePublished - Oct 2007

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)


Dive into the research topics of 'Translation of pharmacogenetics into clinically relevant testing modalities'. Together they form a unique fingerprint.

Cite this